Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
07/2004
07/22/2004WO2004060890A1 2-oxopyridin-3-yl thia (di) azole derivates for use in the treatment of cell proliferation and apoptosis related diseases
07/22/2004WO2004060889A1 5-thiazole substituted 2-pyrrolidine-carboxylic acids
07/22/2004WO2004060888A1 Novel cb 1 receptor inverse agonists
07/22/2004WO2004060883A1 Pyrimidine-4,6-dicarboxylic acid diamides for use as selective mmp 13 inhibitors
07/22/2004WO2004060880A1 Aminoalkyl thiazole derivatives as kcnq modulators
07/22/2004WO2004060879A2 Cyclization process for substituted benzothiazole derivatives
07/22/2004WO2004060874A1 Imino acid derivatives for use as inhibitors of matrix metalloproteinases
07/22/2004WO2004060871A1 Indole-phenylsulfonamide derivatives used as ppar-delta activating compounds
07/22/2004WO2004060865A2 N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
07/22/2004WO2004060371A1 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines
07/22/2004WO2004060362A2 COMPOSITIONS AND METHODS FOR INHIBITING TGF-β
07/22/2004WO2004060306A2 Anti-inflammatory medicaments
07/22/2004WO2004060305A2 Anti-cancer medicaments
07/22/2004WO2004060281A2 2-aryl thiazole derivatives as kcnq modulators
07/22/2004WO2003087086A3 Substituted indoles
07/22/2004WO2003044014A8 Indole-2-carboxamides as factor xa inhibitors
07/22/2004WO2002088090A3 Pyrazole derived kinase inhibitors
07/22/2004US20040143115 e.g., 1-[2-Benzoxazol-2-ylaminomethyl)-piperidin-1-yl]-1-(2-methyl-5phenyl-thiazol4-yl)-methanone; used to treat disorders where an antagonist of a human orexin receptor is required
07/22/2004US20040143018 Thrombosis; emphysema; antihistamines; cirrhosis; antiarthritic agents; anticancer agenst
07/22/2004US20040142999 Novel compounds and compositions as cathepsin inhibitors
07/22/2004US20040142986 Controlling transforming growth facor; artificial skin; wound healing agents
07/22/2004US20040142981 Sterilization, antiseptics for bacteria infections
07/22/2004US20040142979 Cardiovascular disorders; respiratory system disorders; kidneys; liver diosrders; central nervous system diosrders; osteoarthritis; antiarthritic agents; antitumor agents; multiple sclerosis
07/22/2004US20040142978 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
07/22/2004US20040142971 Benzothiophene compounds having antiinfective activity
07/22/2004US20040142967 Pain maintenance
07/22/2004US20040142966 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
07/22/2004US20040142965 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
07/22/2004US20040142963 Cardiovascular disorders
07/22/2004US20040142948 Cardiovascular disorders; hypotensive agents ; respiratory system disorders; antiinflammatory agents; restenosis ; antiarthritic agents; atherosclerosis; anticholesterol agents; Alzheimer's disease; antidiabetic agents
07/22/2004US20040142933 treatment of schizophrenia and other central nervous system (CNS) disorders
07/22/2004US20040142932 treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase activity
07/22/2004US20040142930 excellent phosphodiesterase V (PDE V) inhibitory activity, and being useful as a remedy for the prophylaxis or treatment of penile erectile dysfunction with few side effects
07/22/2004US20040142924 6-Phenylpyridyl-2-amine derivatives useful as NOS inhibitors
07/22/2004US20040142922 Benzodioxole derivatives
07/22/2004US20040142920 acute or chronic transplant rejection or inflammatory or autoimmune diseases
07/22/2004DE10300973A1 Neue Carbonsäuren und deren Ester, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung New carboxylic acids and esters thereof, pharmaceutical compositions containing them and processes for their preparation
07/22/2004DE10300398A1 Verwendung von substituierten 2-Phenylbenzimidazolen als Arzneimittel Use of substituted 2-Phenylbenzimidazolen as drugs
07/22/2004CA2513627A1 Anti-inflammatory medicaments
07/22/2004CA2512502A1 Indole-phenylsulfonamide derivatives used as ppar-delta activating compounds
07/22/2004CA2512361A1 Cyclization process for substituted benzothiazole derivatives
07/22/2004CA2512346A1 Imino acid derivatives for use as inhibitors of matrix metalloproteinases
07/22/2004CA2512183A1 Pyrimidine-4,6-dicarboxylic acid diamides for use as selective mmp 13 inhibitors
07/22/2004CA2511905A1 Novel cb 1 receptor inverse agonists
07/22/2004CA2511873A1 Modulation of protein functionalities
07/22/2004CA2511840A1 Anti-cancer medicaments
07/22/2004CA2509213A1 2-oxopyridin-3-yl thia (di) azole derivates for use in the treatment of cell proliferation and apoptosis related diseases
07/21/2004EP1438304A1 Novel substituted 4-phenyl-4- 1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists
07/21/2004EP1438298A1 Piperazine derivatives with ccr1 receptor antagonist activity
07/21/2004EP1438288A1 Substituted thioacetamides
07/21/2004EP1438053A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same
07/21/2004EP1438049A2 Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage
07/21/2004EP1438046A2 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use
07/21/2004EP0932402B1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
07/21/2004CN1514833A Novel tyrosine kinase inhibitors
07/21/2004CN1514831A Medicinal composition containing 1,3-thiazine derivative
07/21/2004CN1514830A Thiazolyl-substituted carbocyclic 1,3-diones as pesticidal agents
07/21/2004CN1514829A Novel herbicides
07/21/2004CN1513850A Rhodoalkane kind compound, synthesis method and its use
07/21/2004CN1513844A New Carboxglic acid derivative, its preparation and application
07/21/2004CN1158277C Farnesyl transferase inhibitors having piperidine structure and process for preparation thereof
07/21/2004CN1158269C 4-aminothiazole 2 group compound as inhibitors of cyclin-dependent kinases
07/21/2004CN1158264C Metabotropic glutamate receptor antagonists for treating central nervous system disease
07/20/2004US6765013 Thiazolidinedione derivatives for the treatment of diabetes and other diseases
07/20/2004US6765012 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation
07/20/2004US6765009 1,4-Disubstituted benzo-fused compounds
07/20/2004US6765008 Pyrrolopyrimidines as CRF antagonists
07/15/2004WO2004058911A2 Organic electroluminescent element
07/15/2004WO2004058760A1 Thiazole compounds as integrin receptor antagonists derivatives
07/15/2004WO2004058754A1 Benzoazolypiperazine derivatives having mglur1- and mglur5-antagonistic activity
07/15/2004WO2004058753A1 Thiadiazoles or oxadiazoles and their use as inhibitors of jak protein kinase
07/15/2004WO2004058752A1 Quinazoline compounds
07/15/2004WO2004058751A1 Piperidinyl-thiazole carboxamide derivatives for altering vascular tone
07/15/2004WO2004058750A1 Piperidinyl-thiazole carboxylic acid derivatives as angiogenesis inhibitors
07/15/2004WO2004058749A1 Benzisoxazole derivatives useful as inhibitors of protein kinases
07/15/2004WO2004058743A1 Novel substituted nitrogen-containing heterobicycles and use thereof as factor xa inhibitors
07/15/2004WO2004058741A1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
07/15/2004WO2004058740A1 Amino-substituted oligothiophenes as organic semiconductor materials
07/15/2004WO2004058730A2 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
07/15/2004WO2004058729A1 New pyridazin-3(2h)-one derivatives
07/15/2004WO2004058722A1 Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a
07/15/2004WO2004058718A1 4-oxo-3-(1-oxo-1h-isoquinolin-2-ylacetylamino)-pentanoic acid ester and amide derivatives and their use as caspase inhibitors
07/15/2004WO2004058713A1 Differential tumor cytotoxocity compounds and compositions
07/15/2004WO2004058702A2 4-[(4-(carboxyethyl) piperidinyl) methyl] pyrrolidines as modulators of chemokine receptor activity
07/15/2004WO2004058255A1 4, 5-diarylthiazole derivatives as cb-1 ligands
07/15/2004WO2004058174A2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
07/15/2004WO2004058150A2 Anti-infectives
07/15/2004WO2004058144A2 Antibacterial agents
07/15/2004WO2004052887A3 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
07/15/2004WO2004046122A3 Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors
07/15/2004WO2004041163A3 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity
07/15/2004WO2004033632A3 Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)
07/15/2004WO2004032848A3 Pgd2 receptor antagonists for the treatment of inflammatory diseases
07/15/2004WO2004032846A3 Triazolone and triazolethione derivatives
07/15/2004WO2004026248A3 Octahydro-2-h-naphtho[1,2-f] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators
07/15/2004WO2004014881B1 '1,2,4'oxadiazoles as modulators of metabotropic glutamate receptor-5
07/15/2004WO2004006846A3 Receptor-type kinase modulators and methods of use
07/15/2004WO2003086294A3 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
07/15/2004WO2003075836A3 Cathepsin cysteine protease inhibitors
07/15/2004WO2003011853A8 6-aryl-4-aminopicolinates and their use as herbicides